Skip to content
AusGrant
Federal Open GRANTS-GOV-354573

Minor Use Minor Species Development of Drugs (R01)

Food and Drug Administration (HHS) · Competitive grant · Science & Technology

At a glance

Minor Use Minor Species Development of Drugs (R01) is a federal competitive grant from Food and Drug Administration for the science & technology sector. Funding is up to $250K. Eligible applicants: Special district governments; For profit organizations other than small businesses; Native American tribal governments (Federally recognized); Others (see text field entitled "Additional Information on Eligibility" for c. The application deadline is January 29, 2027. Apply via the official listing at www.grants.gov.

Amount
Up to $250K
Deadline
Jan 29, 2027
Type
Competitive
Status
Open

About this program

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS).  The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs. Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants. The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516. FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

Who can apply

Special district governments; For profit organizations other than small businesses; Native American tribal governments (Federally recognized); Others (see text field entitled "Additional Information on Eligibility" for clarification); Independent school districts; Private institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; City or township governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Public and State controlled institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); County governments; Small businesses; Public housing authorities/Indian housing authorities. • Faith-based or Community-based Organizations• Regional Organizations• Non-domestic (non-U.S.) Entities (Foreign Organizations)

How to apply

Apply through Grants.gov using funding opportunity number PAR-24-216. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.

Apply at official source